News by Scott Thomas

Type 2 diabetes drug Avandia linked to osteoporosis and bone loss

Researchers believe that the diabetes drug Avandia may cause bone loss and long-term use may speed up osteoporosis. The thinning of the bones is dangerous and could lead to fatal fractures. The study published in the December 2nd issue of Nature Medicine suggests that usage of rosiglitazone in the treatment of type II diabetes may cause osteoporosis.

Read the rest of this entry »

GSK Sent Avandia meta analysis before publication

GlaxoSmithKline’s Avandia is once again making the headlines after it was revealed that the peer reviewer looking at the now-notorious meta-analysis on the drug’s safety profile leaked a confidential copy of the article to the firm before it was published in the New England Journal of Medicine

Read the rest of this entry »

Avandia study shows increased heart risks or death

Older patients who took Avandia had a higher risk of heart attacks, congestive and death than those on other diabetes pills, according to a study of nearly 160,000 Canadians.

Read the rest of this entry »

Avandia a big risk to your heart

Montgomery, AL: Joyce A. says she did not know that Avandia could cause so many health problems, at least she did not know until her doctor took her off Avandia and put her on another drug. Unfortunately, this happened after she was hospitalized two times with severe chest pains. Although she has started to recover since being taken off Avandia, she says she still experiences some pain.

Read the rest of this entry »

Avandia starting to sound a lot like Vioxx

Mark D. is fighting for justice on behalf of his brother, Grant, whose health has gone downhill since he was prescribed Avandia.

Read the rest of this entry »

Avandia heart attacks seen in general patient population

The consequences of deadly Avandia side-effects are now being seen in the general population, a new study has found. Previously, evidence that Avandia placed patients at an increased risk of had only been seen in clinical trials. But now, Canadian researchers have found that patients taking the controversial diabetes drug who are not enrolled in clinical trials are showing increased evidence of and other cardiac problems.

Read the rest of this entry »

Avandia risks highlighted

Canadian researchers furnished the strongest evidence to date linking the popular diabetes drug Avandia to an increased risk of heart attack in a scientific study released yesterday.

Read the rest of this entry »

New Avandia study reaffirms heart risk

Older patients who took Avandia had a higher risk of heart attacks, congestive and death than those on other diabetes pills, according to a study of nearly 160,000 Canadians out Wednesday.

Read the rest of this entry »

Diabetes drug Avandia could weaken bones

Avandia, a drug used by millions of patients, may contribute to bone loss, according to a new study conducted in mice.

Read the rest of this entry »

Two U.S. healthcare providers drop Glaxo’s Avandia

Two U.S. pharmacy benefit managers said on Thursday they had dropped GlaxoSmithKline Plc’s (.L: Quote, Profile, Research) drug Avandia from their national formularies due to safety concerns.

Read the rest of this entry »